As of December 31, 2011, there were no assets held for sale and liabilities directly related to assets held for sale. In the consolidated balance sheet as of December 31, 2010, the values for the Crop BioScience business were disclosed under this item. The sale of this business to Novozymes A/S closed in the first quarter of 2011.
The following table presents this item in more detail:
| XLS |
|
|
|
|
|
€ million |
31.12.2011 |
31.12.2010 |
|
Current assets |
|
|
|
Cash and cash equivalents |
– |
1.2 |
|
Inventories |
– |
4.6 |
|
Receivables |
– |
10.6 |
|
Other current assets |
– |
0.6 |
|
|
– |
17.0 |
|
Non-current assets |
|
|
|
Intangible assets |
– |
13.4 |
|
Property, plant and equipment |
– |
4.4 |
|
Other non-current assets |
– |
1.9 |
|
|
– |
19.7 |
|
Assets held for sale |
– |
36.7 |
|
|
|
|
|
Current liabilities |
|
|
|
Trade accounts payable |
– |
1.0 |
|
Other current liabilities |
– |
4.7 |
|
|
– |
5.7 |
|
Non-current liabilities |
– |
0.2 |
|
|
|
|
|
Liabilities directly related to assets held for sale |
– |
5.9 |